{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:42:52Z","timestamp":1761964972179,"version":"build-2065373602"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":2076,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:p>Amniotic fluid embolus, also known as anaphylactoid syndrome of pregnancy is a rare complication of pregnancy. When it occurs, the maternal mortality rate may be as high as 86%, and in survivors, the morbidity rate may be just as high. Hallmark clinical features include maternal cardiovascular collapse with cyanosis, cardiopulmonary arrest, hypotension, hemorrhage associated with disseminated intravascular coagulation, and fetal distress. Management centers on strategies to improve oxygenation, support circulation, and correct the coagulopathy. We report the case of a patient who developed amniotic fluid embolus and was effectively managed with aprotinin to control the coagulopathy associated with this devastating complication of pregnancy.<\/jats:p>","DOI":"10.1592\/phco.26.5.689","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T12:16:58Z","timestamp":1301487418000},"page":"689-693","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Aprotinin in the Management of Coagulopathy Associated with Amniotic Fluid Embolus"],"prefix":"10.1002","volume":"26","author":[{"given":"Jeffrey S.","family":"Stroup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Davin","family":"Haraway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Martin","family":"Beal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03019822"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8545(05)70088-7"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2004.06.002"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200304000-00006"},{"issue":"7","key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00007611-200007000-00018","article-title":"Amniotic fluid embolism","volume":"93","author":"Green BT","year":"2000","journal-title":"South Med J"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91474-9"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9572(99)00140-9"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1981.tb10244.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04173.x"},{"issue":"4","key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1051\/ject\/2003354326","article-title":"Biochemistry of serine protease inhibitors and their mechanisms of action: a review","volume":"35","author":"Wegner J","year":"2003","journal-title":"J Extra Corpor Technol"},{"issue":"6","key":"e_1_2_1_12_2","first-page":"s653","article-title":"Aprotinin: a pharmacologic overview","volume":"27","author":"Levy JH","year":"2004","journal-title":"Orthopedics"},{"issue":"5","key":"e_1_2_1_13_2","first-page":"621","article-title":"The use of micro\u2010dose aprotinin with continuous infusion in coronary artery bypass surgery","volume":"40","author":"Holmes JH","year":"1999","journal-title":"J Cardiovasc Surg"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199201000-00026"},{"issue":"5","key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2106\/00004623-200005000-00008","article-title":"Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement","volume":"82","author":"Murkin JM","year":"2000","journal-title":"J Bone Joint Surg"},{"key":"e_1_2_1_16_2","first-page":"367","article-title":"Aprotinin therapy in septic shock [letter]","volume":"155","author":"Putterman C","year":"1989","journal-title":"Acta Chir Scand"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02111-5"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000268378"},{"issue":"1","key":"e_1_2_1_19_2","first-page":"25","article-title":"Amniotic fluid embolism with coagulation disorder: a case report [in German]","volume":"42","author":"Oney T","year":"1982","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"11","key":"e_1_2_1_20_2","first-page":"887","article-title":"Pathomechanisms, signs, symptoms and management of amniotic fluid embolism [in German]","volume":"38","author":"Greaff H","year":"1978","journal-title":"Geburtshilfe Frauenheilkd"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.26.5.689","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.26.5.689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:46:10Z","timestamp":1761054370000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.26.5.689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1592\/phco.26.5.689"],"URL":"https:\/\/doi.org\/10.1592\/phco.26.5.689","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}